Cardiovascular disease in patients with severe mental illness

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Cardiovascular disease in patients with severe mental illness. / Nielsen, René Ernst; Banner, Jytte; Jensen, Svend Eggert.

I: Nature Reviews Cardiology, Bind 18, Nr. 2, 02.2021, s. 136-145.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Nielsen, RE, Banner, J & Jensen, SE 2021, 'Cardiovascular disease in patients with severe mental illness', Nature Reviews Cardiology, bind 18, nr. 2, s. 136-145. https://doi.org/10.1038/s41569-020-00463-7

APA

Nielsen, R. E., Banner, J., & Jensen, S. E. (2021). Cardiovascular disease in patients with severe mental illness. Nature Reviews Cardiology, 18(2), 136-145. https://doi.org/10.1038/s41569-020-00463-7

Vancouver

Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nature Reviews Cardiology. 2021 feb.;18(2):136-145. https://doi.org/10.1038/s41569-020-00463-7

Author

Nielsen, René Ernst ; Banner, Jytte ; Jensen, Svend Eggert. / Cardiovascular disease in patients with severe mental illness. I: Nature Reviews Cardiology. 2021 ; Bind 18, Nr. 2. s. 136-145.

Bibtex

@article{ee1e0a79b6694f58a16a392a6c98c1dd,
title = "Cardiovascular disease in patients with severe mental illness",
abstract = "Individuals diagnosed with schizophrenia or bipolar disorder have a life expectancy 15–20 years shorter than that in the general population. The rate of unnatural deaths, such as suicide and accidents, is high for these patients. Despite this increased proportion of unnatural deaths, physical conditions account for approximately 70% of deaths in patients with either schizophrenia or bipolar disorder, with cardiovascular disease contributing 17.4% and 22.0% to the reduction in overall life expectancy in men and women, respectively. Risk factors for cardiovascular disease, such as smoking, unhealthy diet and lack of exercise, are common in these patients, and lifestyle interventions have been shown to have small effects. Pharmacological interventions to reduce risk factors for cardiovascular disease have been proven to be effective. Treatment with antipsychotic drugs is associated with reduced mortality but also with an increased risk of weight gain, dyslipidaemia and diabetes mellitus. These patients have higher risks of both myocardial infarction and stroke but a lower risk of undergoing interventional procedures compared with the general population. Data indicate a negative attitude from clinicians working outside the mental health fields towards patients with severe mental illness. Education might be a possible method to decrease the negative attitudes towards these patients, thereby improving their rates of diagnosis and treatment.",
author = "Nielsen, {Ren{\'e} Ernst} and Jytte Banner and Jensen, {Svend Eggert}",
year = "2021",
month = feb,
doi = "10.1038/s41569-020-00463-7",
language = "English",
volume = "18",
pages = "136--145",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "nature publishing group",
number = "2",

}

RIS

TY - JOUR

T1 - Cardiovascular disease in patients with severe mental illness

AU - Nielsen, René Ernst

AU - Banner, Jytte

AU - Jensen, Svend Eggert

PY - 2021/2

Y1 - 2021/2

N2 - Individuals diagnosed with schizophrenia or bipolar disorder have a life expectancy 15–20 years shorter than that in the general population. The rate of unnatural deaths, such as suicide and accidents, is high for these patients. Despite this increased proportion of unnatural deaths, physical conditions account for approximately 70% of deaths in patients with either schizophrenia or bipolar disorder, with cardiovascular disease contributing 17.4% and 22.0% to the reduction in overall life expectancy in men and women, respectively. Risk factors for cardiovascular disease, such as smoking, unhealthy diet and lack of exercise, are common in these patients, and lifestyle interventions have been shown to have small effects. Pharmacological interventions to reduce risk factors for cardiovascular disease have been proven to be effective. Treatment with antipsychotic drugs is associated with reduced mortality but also with an increased risk of weight gain, dyslipidaemia and diabetes mellitus. These patients have higher risks of both myocardial infarction and stroke but a lower risk of undergoing interventional procedures compared with the general population. Data indicate a negative attitude from clinicians working outside the mental health fields towards patients with severe mental illness. Education might be a possible method to decrease the negative attitudes towards these patients, thereby improving their rates of diagnosis and treatment.

AB - Individuals diagnosed with schizophrenia or bipolar disorder have a life expectancy 15–20 years shorter than that in the general population. The rate of unnatural deaths, such as suicide and accidents, is high for these patients. Despite this increased proportion of unnatural deaths, physical conditions account for approximately 70% of deaths in patients with either schizophrenia or bipolar disorder, with cardiovascular disease contributing 17.4% and 22.0% to the reduction in overall life expectancy in men and women, respectively. Risk factors for cardiovascular disease, such as smoking, unhealthy diet and lack of exercise, are common in these patients, and lifestyle interventions have been shown to have small effects. Pharmacological interventions to reduce risk factors for cardiovascular disease have been proven to be effective. Treatment with antipsychotic drugs is associated with reduced mortality but also with an increased risk of weight gain, dyslipidaemia and diabetes mellitus. These patients have higher risks of both myocardial infarction and stroke but a lower risk of undergoing interventional procedures compared with the general population. Data indicate a negative attitude from clinicians working outside the mental health fields towards patients with severe mental illness. Education might be a possible method to decrease the negative attitudes towards these patients, thereby improving their rates of diagnosis and treatment.

UR - http://www.scopus.com/inward/record.url?scp=85094660536&partnerID=8YFLogxK

U2 - 10.1038/s41569-020-00463-7

DO - 10.1038/s41569-020-00463-7

M3 - Review

C2 - 33128044

AN - SCOPUS:85094660536

VL - 18

SP - 136

EP - 145

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 2

ER -

ID: 258440630